In further validation, we confirmed the mechanism of action of BARX2 in NPC, which blocked the Ras signaling pathway through transcriptional repression of KRT16, thus inhibiting the growth and metastasis of NPC. The gene discussed is BARX2; the disease is nasopharyngeal carcinoma.